Stage IV neuroblastoma in patients over 1 year of age at diagnosis: consolidation of poor responders with combined busulfan, cyclophosphamide and melphalan followed by In vitro mafosfamide-Purged autologous bone marrow transplantation

Author： Hartmann O.   Valteau-Couanet D.   Benhamou E.   Vassal G.   Rubie H.   Beaujean F.   Lemerle J.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.12, 1997-10, pp. : 2126-2129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-dose Therapy Followed by Autologous Bone Marrow Transplantation in Previously Untreated High Grade Non-Hodgkin's Lymphoma: 10-year Long-term Results

By Zinzani P.L.   Gherlinzoni F.   Bendandi M.   Tura S.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2421-2422

Elsevier

Access to resources Recommend Favorite

Etoposide and Thiotepa Followed by ABMT (Autologous Bone Marrow Transplantation) in Children and Young Adults with High-grade Gliomas

By Bouffet E.   Mottolese C.   Jouvet A.   Philip I.   Frappaz D.   Carrie C.   Brunat-Mentigny M.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 91-95

Elsevier

Access to resources Recommend Favorite

Macroscopic Diagnosis of Metastatic Neuroblastoma on a Bone Marrow Film

By Campidelli Arnaud   Lesesve Jean-Francois  

The Journal of OncoPathology, Vol. 1, Iss. 1, 2013-04 ,pp. : 80-81

Optimal Clinical Ltd

Access to resources Recommend Favorite

Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease - a prospective randomised trial

By van Agthoven M.   Vellenga E.   Fibbe W.E.   Kingma T.   Uyl-de Groot C.A.  

European Journal of Cancer, Vol. 37, Iss. 14, 2001-09 ,pp. : 1781-1789

Elsevier

Access to resources Recommend Favorite

Treatment of chronic myeloid leukemia with autologous transplantation using peripheral blood stem cells or bone marrow cultured in IL-2 followed by IL-2, GM-CSF, and IFN-α administration

By Hájek Roman   Zácková Daniela   Büchler Tomás   Penka Miroslav   Krahulcová Eva   Korśstek Zdenek   Vinklárková Jaroslava   Adler Jirí   Janovská Eva   Indrák Karel   Faber Edgar   Doubek Michal   Klabusay Martin   Oltová Alexandra   Kuglík Petr   Bourková Ludmila   Dusek Ladislav   Mareschová Iveta   Mayer Jirí   Vorlícek Jirí  

Medical Oncology, Vol. 20, Iss. 1, 2003-03 ,pp. : 69-76

Humana Press, Inc

Access to resources Recommend Favorite